618 related articles for article (PubMed ID: 30271147)
1. Theranostic applications of nanoparticles in neurodegenerative disorders.
Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
[TBL] [Abstract][Full Text] [Related]
2. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics.
Lamptey RNL; Chaulagain B; Trivedi R; Gothwal A; Layek B; Singh J
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163773
[TBL] [Abstract][Full Text] [Related]
3. Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers.
Poovaiah N; Davoudi Z; Peng H; Schlichtmann B; Mallapragada S; Narasimhan B; Wang Q
Nanoscale; 2018 Sep; 10(36):16962-16983. PubMed ID: 30182106
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis.
Shukla R; Singh A; Handa M; Flora SJS; Kesharwani P
Drug Discov Today; 2021 Aug; 26(8):1972-1979. PubMed ID: 33892144
[TBL] [Abstract][Full Text] [Related]
5. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
[TBL] [Abstract][Full Text] [Related]
7. Current Strategies for Brain Drug Delivery.
Dong X
Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336
[TBL] [Abstract][Full Text] [Related]
8. Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders.
Nguyen KT; Pham MN; Vo TV; Duan W; Tran PH; Tran TT
Curr Drug Metab; 2017; 18(9):786-797. PubMed ID: 28124594
[TBL] [Abstract][Full Text] [Related]
9. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
10. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
Tripathi P; Shukla P; Bieberich E
Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnological applications for the treatment of neurodegenerative disorders.
Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
[TBL] [Abstract][Full Text] [Related]
12. Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.
Zhang W; Mehta A; Tong Z; Esser L; Voelcker NH
Adv Sci (Weinh); 2021 May; 8(10):2003937. PubMed ID: 34026447
[TBL] [Abstract][Full Text] [Related]
13. Nanotheranostic agents for neurodegenerative diseases.
Padmanabhan P; Palanivel M; Kumar A; Máthé D; Radda GK; Lim KL; Gulyás B
Emerg Top Life Sci; 2020 Dec; 4(6):645-675. PubMed ID: 33320185
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
[TBL] [Abstract][Full Text] [Related]
15. Strategies for transporting nanoparticles across the blood-brain barrier.
Zhang TT; Li W; Meng G; Wang P; Liao W
Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
[TBL] [Abstract][Full Text] [Related]
16. Theranostical application of nanomedicine for treating central nervous system disorders.
Ran W; Xue X
Sci China Life Sci; 2018 Apr; 61(4):392-399. PubMed ID: 29675554
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
Rajpoot K
Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
[TBL] [Abstract][Full Text] [Related]
19. Envisioning the Future of Nanomedicines in Management and Treatment of Neurological Disorders.
Kumar S; Singh P; Sharma S; Pottoo FH; Ali J; Baboota S
Comb Chem High Throughput Screen; 2021; 24(10):1544-1556. PubMed ID: 33334281
[TBL] [Abstract][Full Text] [Related]
20. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
